| Date | Title | Description | Source |
| 10.01.2022 | IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releas... | BRANFORD, Conn., Jan. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis (NASDAQ: ISO), the Superhuman Cell Comp... | marketscre... |
| 10.01.2022 | IsoPlexis : Reports Preliminary Full Year 2021 Revenue, Rele... | IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Librar... | marketscre... |
| 30.11.2021 | IsoPlexis Appoints Key Financial and Legal Hires from Leadin... | BRANFORD, Conn., Nov. 30, 2021 /PRNewswire/ -- IsoPlexis (NASDAQ: ISO), the leader in functional sin... | marketscre... |
| 10.11.2021 | IsoPlexis Reports Third Quarter 2021 Financial Results | BRANFORD, Conn., Nov. 10, 2021 /PRNewswire/ -- IsoPlexis Corporation (Nasdaq: ISO), the leader in fu... | marketscre... |
| 12.10.2021 | IsoPlexis : Announces Closing of Public Offering | BRANFORD, Conn., Oct. 12, 2021 /PRNewswire/ -- IsoPlexis Corporation ("IsoPlexis"), a lead... | marketscre... |
| 08.10.2021 | IsoPlexis : Announces Pricing of Initial Public Offering | BRANFORD, Conn., Oct. 7, 2021 /PRNewswire/ -- IsoPlexis Corporation ("IsoPlexis"), a leade... | marketscre... |
| 08.10.2021 | IsoPlexis, a company uncovering a ‘new layer’ of cell data, ... | Shares of IsoPlexis, a company creating tools to zoom in on the flurry of protein activity surroundi... | techcrunch... |
| 24.06.2021 | Lyndra banks $60.5M to bring ultralong-acting pill into pivo... | As Lyndra Therapeutics mulls partnerships to build out its pipeline of central nervous system disord... | fiercebiot... |
| 24.06.2021 | Belldegrun's VC firm nabs a major $825M funding well for nex... | After an illustrious career in biotech, including navigating Kite Pharma and then Allogene to become... | fiercebiot... |
| 23.06.2021 | Portable dialysis machine maker Quanta lands $245M to boost ... | After starting off 2021 with an FDA clearance for its portable dialysis machine, Quanta Dialysis Tec... | fiercebiot... |
| 23.06.2021 | Strand snags $52M to develop next-gen mRNA meds for cancer
... | For many, mRNA-based medicines are synonymous with COVID-19 vaccines, but vaccination is just the ti... | fiercebiot... |
| 23.06.2021 | Abata hopes to find ‘perfect fit’ with MS cell therapy after... | EMBARGOED until Wednesday, June 23 at 7 a.m. ET
Third Rock is joined by ElevateBio, Lightspeed Vent... | fiercebiot... |
| 22.06.2021 | Blackstone, Cellex and Intellia form $250M CAR-T startup
Ar... | Blackstone Life Sciences, Cellex Cell Professionals and Intellia Therapeutics have teamed to create ... | fiercebiot... |
| 22.06.2021 | TRexBio has Jurassic day picking up ex-Lilly VP as CEO, snag... | The next installment of the "Jurassic Park" franchise doesn't hit theaters for another 12 ... | fiercebiot... |
| 22.06.2021 | Insilico Medicine scores $255M venture round to move AI-desi... | The advent of artificial intelligence holds the promise to reset the industry’s expectations of how ... | fiercebiot... |
| 21.06.2021 | Cleerly launches with $43M to tackle heart attacks with AI-p... | Using artificial intelligence-powered imaging tech developed at Weill Cornell Medicine and New York-... | fiercebiot... |
| 26.05.2021 | Slone Partners Places Siddhartha Kadia on Board of Directors... | “Siddhartha Kadia is a highly accomplished and esteemed scientist and biotechnology business leader ... | prweb.com/... |
| 11.01.2021 | IsoPlexis secures $135M to boost its single-cell protein ana... | As single-cell analysis technologies continue their rapid development—promising a cell’s-eye view of... | fiercebiot... |
| 07.01.2021 | IsoPlexis Announces $135M Series D Round |
BRANFORD, CT, IsoPlexis, the leader in single-cell functional proteomics, announced a $135 million... | vcnewsdail... |
| 07.01.2021 | IsoPlexis Announces $135 Million Financing Led by Perceptive... |
BRANFORD, Conn., Jan. 7, 2021 /PRNewswire/ -- IsoPlexis, the leader in single-cell functional prot... | prnewswire... |
| 07.01.2021 | IsoPlexis Announces $135 Million Series D Led by Perceptive ... | IsoPlexis, the leader in single-cell functional proteomics, today announced a $135 million Series D ... | citybizlis... |
| 11.11.2020 | IsoPlexis Launches Personalized Lab System, the IsoSpark, to... |
BRANFORD, Conn., Nov. 11, 2020 /PRNewswire/ -- IsoPlexis today announced the launch of their groun... | prnewswire... |
| 09.01.2020 | IsoPlexis Raises Additional $20M in Series C Financing | IsoPlexis, a Branford, Conn.-based developer of single-cell functional proteomics, raised an additio... | finsmes.co... |
| 09.01.2020 | IsoPlexis Closes Additional $20 Million Financing | IsoPlexis, the leader in single-cell functional proteomics, has announced today that it has raised a... | citybizlis... |
| 15.05.2019 | Term Sheet — Wednesday, May 15 | THE UNICORN PARADE
Deals, deals, deals. Here are three to have on your radar today:
Paid Content S... | fortune.co... |
| 14.05.2019 | IsoPlexis Receives $25M Series C Funding |
BRANFORD, CT, IsoPlexis today announced that it had raised $25 million in Series C funding.
>&... | vcnewsdail... |
| 14.05.2019 | IsoPlexis Completes $25 Million Series C Financing | IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in o... | citybizlis... |
| 14.05.2019 | IsoPlexis Closes $25M Series C Financing | IsoPlexis, a Branford, Conn.-based company focused on advancing single-cell biomarkers to address cr... | finsmes.co... |
| 14.05.2019 | Daily funding roundup - May 14th, 2019 | Storr raised $3M; Skylark closed $4M; Webscale landed $14M; Innowatts secured $18.2M
Storr: Storr e... | vator.tv/n... |
| 25.09.2017 | IsoPlexis Raises $13.5M in Series B Financing | IsoPlexis Corporation, a Branford, Conn-based life science company, raised $13.5m in its Series B fi... | finsmes.co... |
| 25.09.2017 | Term Sheet — Monday, September 25 | ELON MUSK STRIKES AGAIN
Good morning, Term Sheet readers.
Paid Content Securing the enterprise wit... | fortune.co... |
| 25.09.2017 | IsoPlexis Raises $13.5M in Series B |
BRANFORD, CT, Life science company at the forefront of single-cell analytics technology and the im... | vcnewsdail... |
| 25.09.2017 | IsoPlexis Raises $13.5 Million Series B | IsoPlexis Corporation (IsoPlexis), a privately held life science company at the forefront of single-... | citybizlis... |
| 29.05.2015 | Yale spinout Isoplexis raises $2.4M for “cellular fingerprin... | It has a patent-pending “biochip” technology that analyzes and “fingerprints” single cells, studying... | medcitynew... |
| 12.08.2014 | IsoPlexis Raises $300K from Connecticut Innovations | IsoPlexis, a Branford, Conn.-based life science research tools company, raised $300k from Connecticu... | finsmes.co... |
| 11.08.2014 | IsoPlexis Raises $300K |
BRANFORD, CT, IsoPlexis, a life science research tools company received a $300,000 investment.
&g... | vcnewsdail... |
| 01.08.2014 | Yale student entrepreneur spinout IsoPlexis raising $1.7 mil... | It has a patent-pending “biochip” technology that analyzes and “fingerprints” single cells, studying... | medcitynew... |
| - | Yale student entrepreneur spinout IsoPlexis raising $1.7 mil... | IsoPlexis, a Yale spinout developing an immunologic assay that helps researchers understand how ther... | medcitynew... |
| - | Yale spinout Isoplexis raises $2.4M for “cellular fingerprin... | More funding on the books for Yale spinout Isoplexis: It just raised $2.4 million of a potential $3.... | medcitynew... |
